Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Regenosine logo — Harnessing the healing potential of adenosine for tissue reg...

Regenosine

Harnessing the healing potential of adenosine for tissue regeneration

Founded 2018 United States Jersey City, United States 2 employees Grant Total: $1.84M Biotechnology, Health Care +1

General Information

Company Name Regenosine
Founded Year 2018
Location United States Jersey City, United States
Employees 2
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Regenosine. To contact Regenosine, visit regenosine.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Regenosine compare?

A PDF of Regenosine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Regenosine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Regenosine

Regenosine is a privately held biotechnology startup founded in 2018, with a vision to revolutionize the treatment of osteoarthritis by leveraging the healing potential of adenosine for tissue regeneration. Their proprietary platform technology focuses on developing and marketing first-in-class regenerative therapies, with a lead product aimed at regenerating cartilage in joints affected by osteoarthritis. Their innovative approach targets the rapidly growing joint preservation market, offering a disease-modifying therapy with uncompromising efficacy relative to existing technologies. This breakthrough has the potential to significantly improve clinical outcomes, enhance patient quality of life, and reduce the overall healthcare costs associated with regenerative medicine. Their most recent investment of $25.00K came in the form of a grant from NJEDA on 16 February 2023. Regenosine operates from the United States, and their emphasis on pioneering regenerative therapies positions them as a promising player within the biotechnology, healthcare, and pharmaceutical industries.

Business keywords: regenerative medicine, osteoarthritis, cartilage regeneration, purinergic system, joint preservation, disease modifying therapy, clinical outcomes, proprietary technology, regenerative therapies, healthcare delivery, patient quality of life

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $25.00K 1
NJEDA
NJEDA
16 Feb 2023
Grant $149.50K 1
NJEDA
NJEDA
02 Aug 2022
Grant $1.67M 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
01 Oct 2021
Seed Round Undisclosed 1
SeedFolio
SeedFolio
01 Jan 2020
Pre Seed Round Undisclosed 1
Creative Destruction Lab
Creative Destruction Lab
12 Jun 2019

Regenosine Alternatives & Competitors

View All Alternatives
Regenosine vs
Cartilage Inc.
Cartilage Inc. United States

Real engineered cartilage for real healing.

Grant
12 employees
Biotechnology, Health Care
Regenosine vs
Tenaya Therapeutics
Tenaya Therapeutics United States

Scaling new heights in the fight against heart disease

Post-IPO Equity
93 employees
Biopharma, Biotechnology
Regenosine vs
ORTEQ Sports Medicine
ORTEQ Sports Medicine United Kingdom

We aim to reduce patient suffering from meniscus and articular cartilage injury or degeneration by c...

Venture round
9 employees
Biotechnology, Health Care
View all alternatives

FAQ About Regenosine

Harnessing the healing potential of adenosine for tissue regeneration
Regenosine was founded in 2018.
Regenosine is headquartered in Jersey City, United States.
Regenosine operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on regenerative medicine, osteoarthritis, cartilage regeneration and purinergic system.
Regenosine has approximately 2 employees.
Regenosine has completed 5 funding rounds, raising a total of $1.84M. The latest funding stage is Grant.
Top alternatives and competitors to Regenosine include Cartilage Inc., Tenaya Therapeutics, ORTEQ Sports Medicine, osteobionix, Amplicore Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Regenosine and Cartilage Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Regenosine, https://bouncewatch.com/company/regenosine, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout